Plunkett Research Online: Epizyme Inc

EPIZYME INC (EPZM:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Epizyme, Inc. is a late-stage biopharmaceutical company that discovers, develops and plans to commercialize novel epigenetic medicines for people with cancer and other serious diseases. By focusing on the genetic drivers of disease, the firm’s science seeks to match targeted medicines with the pati.....



Epizyme Inc
Ticker: EPZM
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617-229-5872
Fax:
Address: 400 Technology Square
4th Floor
Cambridge, MA 02139 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Biopharmaceuticals
ContactsDescription
Robert BazemoreCEO/President/Director
Matthew RosCFO/Other Executive Officer
See More
Epizyme, Inc. is a late-stage biopharmaceutical company that discovers, develops and plans to commercialize novel epigenetic medicines for people with cancer and other serious diseases. By focusing on the genetic drivers of disease, the firm’s science seeks to match targeted medicines with the pati.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
tazemetostat
EZM8266
pinometostat
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: